Back

Exhaled breath acetone as a biomarker of disease severity and exercise intolerance in heart failure

20 May 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: Advances in mechanisms of heart failure Pathophysiology HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Nicolo' De Biase

University Hospital of Pisa, Pisa (Italy)

6 More presentations in this session

Presentation thumbnail
Serum amyloid a1 reflects activation of interleukin 1b, 6, and 17 and is specifically upregulated in heart failure with a preserved ejection fraction
Mr B. Van Essen (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Immune cell signature in non-ischemic heart failure indicates chronic activation and immunosenescence
Mr L. Baumhove (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
EDEM2 is a new therapeutic target for improving diabetes-induced cardiomyopathy by regulating DSG2
Miss J. Zhang (Manchester, GB)
Abstract Slides Video
Presentation thumbnail
Inositol 1,4,5-trisphosphate receptors (ITP3Rs) ablation reduces the expression of chemokine ligands and pro-inflammatory interleukins
Doctor U. Kansakar (Bronx, US)
Abstract Slides Video
Presentation thumbnail
The role of EDEM2 in the heart under metabolic stress
Miss O. Fonseka (Manchester, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Advances in mechanisms of heart failure

The Event

Event poster

Heart Failure 2025

20 May 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
The role of exhaled breath acetone and BNP in predicting outcomes in advanced heart failure
thumbnail
Congress Presentation
Risk stratification for heart transplant listing or death in patients with heart failure profile C - a classification and regression tree CART analysis
thumbnail
Congress Session
Novel biomarkers in heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources